zolmitriptan 2.5 MG Oral Tablet
1 INDICATIONS AND USAGE Zolmitriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use Only use zolmitriptan tablets if a clear diagnosis of migraine has been established. If a patient has no response to zolmitriptan tablets treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan tablets are administered to treat any subsequent attacks. Zolmitriptan tablets are not indicated for the prevention of migraine attacks. Safety and effectiveness of zolmitriptan tablets have not been established for cluster headache. Zolmitriptan tablets are serotonin (5-HT) 1B/1D receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults (1) Limitations of Use: Use only after a clear diagnosis of migraine has been established ( 1 ) Not indicated for the prophylactic therapy of migraine ( 1 ) Not indicated for the treatment of cluster headache ( 1 )
Jubilant Cadista Pharmaceuticals Inc.
ROUND PINK CB7
Related Pills
zolmitriptan 5 MG Oral Tablet
Jubilant Cadista Pharmaceuticals Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 2.5 mg Tablets: Light pink, round, film-coated tablets, debossed with ‘CB7’ on one side and scoreline on the other side. Carton of 3 (1 x 3) unit-dose tablets (child resistant) NDC 59746-432-13 Carton of 6 (2 x 3) unit-dose tablets (child resistant) NDC 59746-432-16 5 mg Tablets: Light pink, round, film-coated tablets, debossed with ‘CB8’ on one side and plain on the other side. Carton of 3 (1 x 3) unit-dose tablets (child resistant) NDC 59746-433-13 Carton of 6 (2 x 3) unit-dose tablets (child resistant) NDC 59746-433-16 Carton of 3 (1 x 3) unit-dose tablets NDC 59746-433-15 Carton of 6 (2 x 3) unit-dose tablets NDC 59746-433-17 Store at 20ºC to 25°C (68ºF to 77ºF), excursions permitted to 15°C to 30°C (59ºF to 86ºF) [See USP Controlled Room Temperature]. Protect from light and moisture.
More pills like ROUND CB7